Malaysia
Search
Sign In
Ophthalmology
Top Medical News
ClickCheck, a portable and low-cost refractive error measurement device, demonstrates a high level of agreement with the standard-practice subjective refraction (SR) in terms of spherical power, according to a recent study. Nevertheless, improvements are needed to yield better cylindrical power evaluations.
There appears to be a genetic-based association between the presence of myopic refractive error and an increased risk of primary open-angle glaucoma (POAG), according to the results of a Mendelian randomization study.
Treatment with bevacizumab in patients undergoing vascularized high-risk corneal transplantation shows no significant difference in the rate of endothelial rejection at 1 year when compared to placebo, reports a recent study.
Current polygenic risk scores (PRSs) deliver satisfactory predictive capacity for high myopia (HM) and can pinpoint children at high risk to prevent myopia progression to HM, suggests a Singapore study.
Topical OCS-01, a dexamethasone ophthalmic suspension, appears to be beneficial in the treatment of patients with diabetic macular edema, with the results of a phase II study showing that the drug helps improve central macular thickness.
While diabetes is a risk factor for cataract, glucose-lowering medications appear to have a protective effect on the risks of open-angle glaucoma (OAG) and age-related macular degeneration (AMD), as shown in a study.
COVID-19 vaccination-induced uveitis is uncommon, with cases mostly self-limiting and showing good responses to treatment with no long-term sequelae, according to a Singapore study. However, reactivation of such infections appears to occur at a higher proportion in Southeast Asia, where viral and toxoplasma infections are more common.
Special Reports
A new algorithm objectively determines when intraocular lens implant (IOL) surgery should be performed, regardless of how the opacity looks to the surgeon.
Bilastine 10 mg orodispersible tablet
Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.
